NCT03602703View on ClinicalTrials.gov

Immune Responses in Hepatocellular Carcinoma Patients After Treatment With Direct Acting Antiviral Drugs

CompletedOBSERVATIONAL
Enrollment

42

Participants

Timeline

Start Date

July 1, 2018

Primary Completion Date

September 1, 2019

Study Completion Date

September 1, 2019

Conditions
Drug-Induced Liver Injury
Interventions
DIAGNOSTIC_TEST

Flow cytometry and Western Blot analysis

Diagnostic tests

Trial Locations (1)

7771

Assiut University, Asyut

All Listed Sponsors
lead

Assiut University

OTHER

NCT03602703 - Immune Responses in Hepatocellular Carcinoma Patients After Treatment With Direct Acting Antiviral Drugs | Biotech Hunter | Biotech Hunter